These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36754848)

  • 1. MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3.
    Asai S; Goto Y; Tanigawa K; Tomioka Y; Kato M; Mizuno K; Sakamoto S; Seki N
    FEBS Lett; 2023 Apr; 597(8):1164-1175. PubMed ID: 36754848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic receptors promote castration-resistant growth of prostate cancer through a FAK-YAP signaling axis.
    Goto Y; Ando T; Izumi H; Feng X; Arang N; Gilardi M; Wang Z; Ando K; Gutkind JS
    Oncogene; 2020 May; 39(20):4014-4027. PubMed ID: 32205868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK-Mediated Phosphorylation of Akt.
    Wang N; Yao M; Xu J; Quan Y; Zhang K; Yang R; Gao WQ
    Clin Cancer Res; 2015 Oct; 21(20):4676-85. PubMed ID: 26071486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.
    Arai T; Kojima S; Yamada Y; Sugawara S; Kato M; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Mol Oncol; 2019 Feb; 13(2):322-337. PubMed ID: 30444038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.
    Guo Y; Cui J; Ji Z; Cheng C; Zhang K; Zhang C; Chu M; Zhao Q; Yu Z; Zhang Y; Fang YX; Gao WQ; Zhu HH
    Oncogene; 2017 Nov; 36(45):6336-6347. PubMed ID: 28745315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis.
    Liu B; Jiang HY; Yuan T; Zhou WD; Xiang ZD; Jiang QQ; Wu DL
    Curr Pharm Des; 2021; 27(41):4261-4269. PubMed ID: 34126893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity.
    Wang Y; Shao N; Mao X; Zhu M; Fan W; Shen Z; Xiao R; Wang C; Bao W; Xu X; Yang C; Dong J; Yu D; Wu Y; Zhu C; Wen L; Lu X; Lu YJ; Feng N
    Oncotarget; 2016 Jul; 7(30):47444-47464. PubMed ID: 27329728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).
    Liu D; Tao T; Xu B; Chen S; Liu C; Zhang L; Lu K; Huang Y; Jiang L; Zhang X; Huang X; Zhang L; Han C; Chen M
    Biochem Biophys Res Commun; 2014 Feb; 445(1):151-6. PubMed ID: 24491557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of CHRM3 Alleviates Necrosis Via the MAPK-p38/miR-31-5p/RIP3 Axis in L-Arginine-Induced Severe Acute Pancreatitis.
    Luan J; Kou J; Huang N; Tao Y; Shi S; Wu X; Sun Y; Meng D; Xu J; Zhou X; Murtaza G; Bobkov A; Qiao Y; Gao X; Ma N
    Pancreas; 2020; 49(10):1335-1341. PubMed ID: 33122522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional roles of miR-625-5p and miR-874-3p in the progression of castration resistant prostate cancer.
    Aktan Ç; Çal Ç; Kaymaz B; Selvi Günel N; Kıpçak S; Özel B; Gündüz C; Şahin Küçükaslan A; Aygüneş Jafari D; Kosova B
    Life Sci; 2022 Jul; 301():120603. PubMed ID: 35508255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of miR-582-5p regulates cellular proliferation of prostate cancer cells under androgen-deprived conditions.
    Maeno A; Terada N; Uegaki M; Goto T; Okada Y; Kobayashi T; Kamba T; Ogawa O; Inoue T
    Prostate; 2014 Dec; 74(16):1604-12. PubMed ID: 25176332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.
    Scaravilli M; Porkka KP; Brofeldt A; Annala M; Tammela TL; Jenster GW; Nykter M; Visakorpi T
    Prostate; 2015 Jun; 75(8):798-805. PubMed ID: 25731699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
    Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer.
    Chen R; Sheng L; Zhang HJ; Ji M; Qian WQ
    J Cell Mol Med; 2018 Mar; 22(3):1855-1863. PubMed ID: 29363862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.
    Jeong JH; Park SJ; Dickinson SI; Luo JL
    Mol Cell; 2017 Jan; 65(1):154-167. PubMed ID: 28041912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-15b-5p inhibits tumor necrosis factor alpha-induced proliferation, migration, and extracellular matrix production of airway smooth muscle cells via targeting yes-associated protein 1.
    Zeng S; Cui J; Zhang Y; Zheng Z; Meng J; Du J
    Bioengineered; 2022 Mar; 13(3):5396-5406. PubMed ID: 35172671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.
    Zheng XM; Zhang P; Liu MH; Chen P; Zhang WB
    Int J Oncol; 2019 Feb; 54(2):443-454. PubMed ID: 30483762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating miR-6880-5p in extracellular vesicle from plasma as a prognostic biomarker in endocrine therapy-treated castration-resistant prostate cancer.
    Lee J; Hong J; Kim JW; Lim S; Choi SC; Gim JA; Kang SG; Noh TI; Park KH
    BMC Cancer; 2024 Jul; 24(1):909. PubMed ID: 39075471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHRM3-Associated miRNAs May Play a Role in Bile Acid-Induced Proliferation of H508 Colon Cancer Cells.
    Aktan Ç; Tekin F; Oruç N; Özütemiz Ö
    Turk J Gastroenterol; 2023 Mar; 34(3):298-307. PubMed ID: 36919835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer.
    Nabavi N; Saidy NRN; Venalainen E; Haegert A; Parolia A; Xue H; Wang Y; Wu R; Dong X; Collins C; Crea F; Wang Y
    Sci Rep; 2017 Jun; 7(1):4079. PubMed ID: 28642484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.